SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoracles

A sharp, high-volume rally has pushed ZORA into the spotlight, with traders focusing on its low market capitalization and speculation that large futures short positions could create a short-squeeze setup. Bullish participants expect further momentum, while skeptics characterize the move as a volatile pump-and-dump.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Heliums deployment of municipal WiFi as carrier-grade coverage in Celina, Texasalongside perceived traction from carrier offload and Helium Mobileis driving renewed attention and bullish momentum. Traders are also debating whether the move reflects real DePIN adoption or a speculative squeeze, with skeptics citing token dilution, weak hotspot economics, and sustainability concerns.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Strong quarterly performance and BioCrysts profitable Orladeyo franchise are driving renewed attention, alongside managements plan to acquire external rare-disease assets after shifting away from internally developed research. Traders remain divided between buyout speculation and concerns about competition from PHVS, dilution, and the long wait for navenibart and BCX17725 data.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

U.S.-Iran strikes near the Strait of Hormuz and fears of retaliation are driving attention, with traders linking higher oil prices to renewed inflation and Federal Reserve rate-hike risk for growth stocks. The community is divided between expecting further downside and arguing that dip-buying, easing oil pressures, and resilient semiconductor earnings will help QQQ recover.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Analyst downgrades and concerns about Norwegian Cruise Lines leverage, debt burden, and delayed demand recovery are driving attention, with traders debating whether the weakness reflects fundamental risk or a buying opportunity. The community also remains focused on oil prices and Iran-related Strait of Hormuz disruptions as key cost and travel-demand variables, while some traders cite Elliott involvement, insider buying, and the turnaround plan as counterpoints.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention over its lockup expiration, which released previously restricted shares and intensified selling, volatility, and debate over whether the closed-end funds premium to NAV can hold. Bulls view anticipated Anthropic, OpenAI, and Databricks listings as a potential counter-catalyst, while skeptics expect the increased supply to push shares closer to NAV.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

A quarterly earnings report that missed revenue expectations and provided softer forward guidance is driving attention, despite management highlighting strong profitability and market-share gains. Traders are divided between viewing the selloff as an overreaction to macro-sensitive housing conditions and focusing on elevated rates, weak housing activity, and valuation concerns.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrikes quarterly results, record recurring-revenue growth and raised full-year outlook have fueled renewed enthusiasm for AI-driven cybersecurity demand and a broader software-sector rally. Traders remain divided, with bulls citing stronger platform adoption and cyber spending while skeptics argue the modest beat and largely in-line near-term guidance do not justify the stocks elevated valuation.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

A strong quarterly earnings beat and upbeat forward outlook, followed by multiple analyst upgrades, drove heavy attention and an initial surge in Affirm shares. Traders are now debating the sharp post-earnings reversal, attributing it to profit-taking, options-related selling and a hawkish macro backdrop, while bears remain focused on valuation and credit risk.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

Anticipation of UiPaths quarterly earnings and investor day is driving attention, with traders focused on ARR growth, guidance, and whether its AI-orchestration strategy can support renewed growth. Bullish traders point to profitability, buybacks, software-sector strength, and high short interest as potential fuel, while skeptics warn that disappointing results or guidance could trigger a sharp pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?

Shares of Intelligent Bio Solutions are surging Monday after it announced a significant regulatory milestone for its rapid testing unit.read more...

INBS Stock Falls After Clinical Study Win: FDA Progress Fails To Lift Shares 

Equity

The company completed its initial clinical study required for FDA approval of its fingerprint-based drug-testing system.

INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership

The company announced the first shipment of its Intelligent Fingerprinting Drug Screening Readers, produced in collaboration with Syrma Johari MedTech.

INBS Stock Has Surged Over 330% So Far In January – But Retail Traders Are Warning Of A Pullback 

INBS shares were up more than 35% in premarket trading on Monday and were among the top trending tickers on Stocktwits.

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

INBS Stock Surges 132.4% on New Manufacturing Partnership 

Intelligent Bio Solutions' stock jumps after a new manufacturing partnership aimed at cutting costs, boosting margins and scaling production ahead of U.S. expansion.

Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Stock Market Today: S&P 500, Dow Futures Gain On The First Trading Day Of 2026 Baidu, Rubico, Intelligent Bio Solutions In Focus

U.S. stock futures rose on the first trading day of the year on Friday after missing the Santa Claus rally over the truncated week. Futures of major benchmark indices were higher. The Santa Claus...

Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today

Wall Street is hoping to break a three-year streak of opening-day losses.


Top Medical Stocks To Consider - January 1st

Eli Lilly and Company, UnitedHealth Group, Intelligent Bio Solutions, Johnson & Johnson, Merck & Co., Inc., Pfizer, and Corcept Therapeutics are the seven Medical stocks to watch today, according to...

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

INBS Intelligent Bio Solutions Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest INBS News